Dieter Gericke

Dieter Gericke
Firm:
Office:
Prime Tower
Hardstrasse 201
CH-8005
City:
Zurich
State:
Zurich
Country:
Switzerland
Tel:
+41 43 222 10 00
Fax:
+41 43 222 15 00

Biographies:

Who's Who Legal Switzerland - Capital Markets

Dieter Gericke heads the corporate and M&A team as well as the Homburger China group. He studied law at the University of Zurich, where he graduated and accomplished his doctorate, both summa cum laude. In 1999, he graduated from Harvard Law School with an LLM.

Dieter Gericke's practice focuses on M&A (including public takeovers and defence), equity capital markets (including IPOs), private equity and financing. He advises in matters of corporate law and governance, as well as securities regulations. He is an authorised issuers' representative at the SIX Swiss Exchange.

Recent assignments include the takeover of Syngenta by ChemChina, the sale of specialty vaccines company PaxVax to Emergent BioSolutions, the acquisition of Haas Group by Bühler Group, the acquisition of Kunststoff Schwanden by Bregal, the acquisition of Activ International by Givaudan, the sale of Infront Sports & Media to Dalian Wanda, the acquisition of Ulysse Nardin by Kering, the IPO of Zur Rose Group and the financing of ADC Therapeutics. He is particularly experienced in the life sciences, engineering, technology and insurance industries.

In his areas of practice, Dieter Gericke authored various publications and legal opinions, including on global M&A, securities laws, directors' and officers' duties and liability and say-on-pay regulations. He is a member of the IBA corporate and M&A as well as securities law committee.

Dieter Gericke is a member of the board of directors of Syngenta, a leading agrotechnology group, and of Gericke Group, which produces powder processing equipment and systems for food, pharma and chemical industries.

WWL says: Dieter Gericke leads the firm's corporate and M&A practice group, and is well respected in the market for his expertise in securities regulation and capital markets transactions.

This biography is an extract from Who's Who Legal: Switzerland which can be purchased from our Shop.

Who's Who Legal Corporate: Merger & Acquisition

Dieter Gericke heads the corporate and M&A practice team as well as the Homburger China group. He studied law at the University of Zurich, where he graduated and accomplished his doctorate, both summa cum laude. In 1999, he graduated from Harvard Law School with an LLM.

Dieter Gericke's practice focuses on M&A (including public takeovers and defence), equity capital markets (including IPOs), private equity and financing. He advises in matters of corporate law and governance, as well as securities regulations. He is an authorised issuers' representative at the SIX Swiss Exchange.

Recent assignments include the takeover of Syngenta by ChemChina, the acquisition of Haas Group by Bühler Group, the acquisition of Kunststoff Schwanden by Bregal, the acquisition of Activ International by Givaudan, the sale of Infront Sports & Media to Dalian Wanda, the acquisition of Ulysse Nardin by Kering, the IPO of Zur Rose Group and the financing of ADC Therapeutics. He is particularly experienced in the life sciences, engineering, technology and insurance industries.

In his areas of practice Dieter Gericke authored various publications and legal opinions, including on mergers & acquisitions, securities laws, directors' and officers' duties and liability and say-on-pay regulations. He is a member of the IBA corporate and M&A and vice-chair of the securities law committee.

Dieter Gericke is a member of the board of directors of Gericke Group, which produces powder processing equipment and systems for food, pharma and chemical industries. In addition, he has served in honorary capacity as a member of the board of supervisors of Theater an der Winkelwiese, Zurich.

WWL says: Dieter Gericke is “an extremely reliable and deal-oriented lawyer” according to sources and is highlighted for his extensive experience handling both public and private M&A deals.

This biography is an extract from Who's Who Legal: Corporate which can be purchased from our Shop.

Who's Who Legal Switzerland - M&A

Dieter Gericke heads the corporate and M&A team as well as the Homburger China group. He studied law at the University of Zurich, where he graduated and accomplished his doctorate, both summa cum laude. In 1999, he graduated from Harvard Law School with an LLM.

Dieter Gericke's practice focuses on M&A (including public takeovers and defence), equity capital markets (including IPOs), private equity and financing. He advises in matters of corporate law and governance, as well as securities regulations. He is an authorised issuers' representative at the SIX Swiss Exchange.

Recent assignments include the takeover of Syngenta by ChemChina, the sale of specialty vaccines company PaxVax to Emergent BioSolutions, the acquisition of Haas Group by Bühler Group, the acquisition of Kunststoff Schwanden by Bregal, the acquisition of Activ International by Givaudan, the sale of Infront Sports & Media to Dalian Wanda, the acquisition of Ulysse Nardin by Kering, the IPO of Zur Rose Group and the financing of ADC Therapeutics. He is particularly experienced in the life sciences, engineering, technology and insurance industries.

In his areas of practice, Dieter Gericke authored various publications and legal opinions, including on global M&A, securities laws, directors' and officers' duties and liability and say-on-pay regulations. He is a member of the IBA corporate and M&A as well as securities law committee.

Dieter Gericke is a member of the board of directors of Syngenta, a leading agrotechnology group, and of Gericke Group, which produces powder processing equipment and systems for food, pharma and chemical industries.

WWL says: Dieter Gericke is "certainly a good name" in the Swiss corporate market according to peers, who praise his outstanding work on complex M&A transactions.

This biography is an extract from Who's Who Legal: Switzerland which can be purchased from our Shop.

Who's Who Legal Corporate: Corporate Governance

Dieter Gericke heads the corporate and M&A practice team as well as the Homburger China group. He studied law at the University of Zurich, where he graduated and accomplished his doctorate, both summa cum laude. In 1999, he graduated from Harvard Law School with an LLM.

Dieter Gericke's practice focuses on M&A (including public takeovers and defence), equity capital markets (including IPOs), private equity and financing. He advises in matters of corporate law and governance, as well as securities regulations. He is an authorised issuers' representative at the SIX Swiss Exchange.

Recent assignments include the takeover of Syngenta by ChemChina, the acquisition of Haas Group by Bühler Group, the acquisition of Kunststoff Schwanden by Bregal, the acquisition of Activ International by Givaudan, the sale of Infront Sports & Media to Dalian Wanda, the acquisition of Ulysse Nardin by Kering, the IPO of Zur Rose Group and the financing of ADC Therapeutics. He is particularly experienced in the life sciences, engineering, technology and insurance industries.

In his areas of practice Dieter Gericke authored various publications and legal opinions, including on mergers & acquisitions, securities laws, directors' and officers' duties and liability and say-on-pay regulations. He is a member of the IBA corporate and M&A and vice-chair of the securities law committee.

Dieter Gericke is a member of the board of directors of Gericke Group, which produces powder processing equipment and systems for food, pharma and chemical industries. In addition, he has served in honorary capacity as a member of the board of supervisors of Theater an der Winkelwiese, Zurich.

WWL says: Sources praise the "very experienced" Dieter Gericke for his corporate governance expertise and the high quality of his work in the area.

This biography is an extract from Who's Who Legal: Corporate which can be purchased from our Shop.

Other Practice Areas:

Follow us on LinkedIn

Practice Areas

Firms

Browse Firms

Search Firms

The Who's Who Legal 100

Awards

News & Features

Special Reports

Events

Shop

About Us

It is not possible to buy entry into any Who's Who Legal publication

Nominees have been selected based upon comprehensive, independent survey work with both general counsel and private practice lawyers worldwide. Only specialists who have met independent international research criteria are listed.

Copyright © 2019 Law Business Research Ltd. All rights reserved. | http://www.lbresearch.com

87 Lancaster Road, London, W11 1QQ, UK | Tel: +44 20 7908 1180 / Fax: +44 207 229 6910

http://www.whoswholegal.com | editorial@whoswholegal.com

Law Business Research Ltd

87 Lancaster Road, London
W11 1QQ, UK